Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
-Top-line data including safety, tolerability, and biomarker activity anticipated this summer-
-This Phase 1 clinical study data will support further development across multiple indications-
Posted In: REVB